about
Influence of catch up growth on spatial learning and memory in a mouse model of intrauterine growth restrictionPreclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum.Diagnostic accuracy of fibrinogen to differentiate appendicitis from nonspecific abdominal pain in children.Newborn screening for Fabry disease in the north-west of Spain.Evolution of Energy Related Metabolites in Plasma from Newborns with Hypoxic-Ischemic Encephalopathy during Hypothermia Treatment.Prenatal Therapy with Magnesium Sulfate and Its Correlation with Neonatal Serum Magnesium Concentration.Evaluation of carnitine deficit in very low birth weight preterm newborns small for their gestational age.[Appendicitis versus nonspecific acute abdominal pain: diagnostic accuracy of ultrasound].[Methylene blue: usefulness in the treatment of refractory hypotension in premature infants].[Early neonatal convulsion: accidental mepivacaine administration][Risk of developmental dysplasia of the hip in patients subjected to the external cephalic version].Neonatal sepsis of nosocomial origin: an epidemiological study from the "Grupo de Hospitales Castrillo".[Appendicitis versus non-specific acute abdominal pain: Paediatric Appendicitis Score evaluation].[Oxidative stress in perinatal asphyxia and hypoxic-ischaemic encephalopathy].[Prenatal treatment with magnesium sulphate: Initial clinical outcomes in pre-term infants less than 29 weeks and correlation with neonatal magnesium levels].Acylcarnitine profile in neonatal hypoxic-ischemic encephalopathy: The value of butyrylcarnitine as a prognostic marker[Recommendations for the care of healthy newborn infants][Encephalocraniocutaneous lipomatosis (Haberland syndrome) with bilateral ocular damage]Serum levels of IGF1 are a useful predictor of retinopathy of prematurity[Respiratory care in neonatal intensive care units. Situation in the year 2005]Inborn errors of metabolism in a neonatology unit: impact and long-term results[Hyperammonaemia. Treatment in the emergency and acute phase of a patient with citrullinaemia][Recommendations for the computerisation of neonatology services][Health care levels and minimum recommendations for neonatal care]Risk factors for developing mineral bone disease in phenylketonuric patients[Recommendations for neonatal transport][Bronchopulmonary dysplasia: definitions and classifications][Recommendations for respiratory support in the newborn (iii). Surfactant and nitric oxide]Corrigendum to "Risk factors for developing mineral bone disease in phenylketonuric patients" [Mol. Genet. Metab. 108 (2013) 149-154][Universal cytomegalovirus infection screening in premature newborns less than 1500 g]Topiramate plus Cooling for Hypoxic-Ischemic Encephalopathy: A Randomized, Controlled, Multicenter, Double-Blinded TrialThe Practicality of Feeding Defatted Human Milk in the Treatment of Congenital ChylothoraxValue of Fibrinogen to Discriminate Appendicitis from Nonspecific Abdominal Pain in Preschool ChildrenNeurodevelopmental Disorders and Array-Based Comparative Genomic Hybridization: Sensitivity and Specificity using a Criteria Checklist for Genetic Test PerformanceAppendicitis or non-specific abdominal pain in pre-school children: When to request abdominal ultrasound?
P50
Q33724871-18A9087B-90FB-4B4B-9D5C-1E4B41947EA3Q35093749-972012E8-A013-45E3-B6D9-D070801EB2CAQ40479517-AE8DE0CD-E409-44F6-A5D4-71CF9488422CQ41020446-91F2203D-E110-4CA4-93D1-7E1443DFBF73Q47139879-FB575CB0-123A-4B98-A749-99402649CB64Q47284816-144656E8-3C9A-48BF-9C71-062C939E5C38Q47399848-80C7F44A-AD2C-474B-8141-F78C7D1B6764Q50086475-2F8C9610-3F8A-441F-8610-637A0303F098Q50283065-8DB166A0-8303-409F-847E-8AD32B69D682Q50331576-E686132A-518C-4257-BCF3-31596ADBB3F4Q50439148-53AEACEB-E490-4FD5-A85D-36CD26765396Q51716999-C2154C68-5519-4AA2-948A-0F34B33E751FQ53733783-4ACF7490-C11D-403F-9B16-5CC9EFEFB648Q53735202-A212759C-607F-4F4B-B43F-69BEEDDD9954Q53786134-117BEC1F-6B1C-45E1-BD7C-A54F3337ECBCQ64235909-198D3AC8-FD79-4E5E-848F-69312909CB06Q74264454-1B6FEC03-7BC1-4187-B5C2-1FFDE1EB4DE8Q80510374-0868B661-43FB-4092-9DBE-3B5947E84433Q82564495-69C669BD-EEBD-4C0F-9981-791B0A739062Q83351802-A50B12FF-00AB-4E22-A1D4-9817A138B7B4Q84296815-1606EC1C-FA1F-4678-92E5-99884E96050EQ84825111-FBB8F7E2-5A4C-4665-B6B4-BBAE67715534Q85535817-CBC2ACF7-69A5-4AE0-B7F1-E8A6FE6A4886Q85783308-BD660939-EA3E-47D9-853D-D8668E947AD8Q85961009-C7FC2B81-778D-4C7C-9177-9742C6F6DEB7Q86190293-55FF8D24-C988-4C8A-9E0F-6DAE8A740DFAQ86587539-E39F3ACC-5ED1-4B2D-ADB4-AD4FE929CF4DQ87052041-8F157678-4E7B-4DA0-84A7-2228149ED7B1Q87121071-45F2C184-A6CB-4EDD-80A4-2F62499F61B0Q87341960-6779E768-A56F-4D76-BFFA-39AB16435319Q92041351-24C36F77-EF3C-41F2-86FC-F1F763033F02Q92559408-1FF111B8-F731-4FB8-B6BF-651745637002Q92686477-B4CF67FB-41C7-44A7-96DC-CD42CAF6AD15Q92792913-11A9E5E8-4E74-4E57-8276-C6B650E88764Q93091855-D17C8C02-703F-464A-89A1-1C1A5BBDE07D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
José Ramón Fernández-Lorenzo
@ast
José Ramón Fernández-Lorenzo
@en
José Ramón Fernández-Lorenzo
@es
José Ramón Fernández-Lorenzo
@nl
José Ramón Fernández-Lorenzo
@sl
type
label
José Ramón Fernández-Lorenzo
@ast
José Ramón Fernández-Lorenzo
@en
José Ramón Fernández-Lorenzo
@es
José Ramón Fernández-Lorenzo
@nl
José Ramón Fernández-Lorenzo
@sl
altLabel
JR Fernandez Lorenzo
@en
prefLabel
José Ramón Fernández-Lorenzo
@ast
José Ramón Fernández-Lorenzo
@en
José Ramón Fernández-Lorenzo
@es
José Ramón Fernández-Lorenzo
@nl
José Ramón Fernández-Lorenzo
@sl
P106
P21
P31
P496
0000-0002-0559-6240